MENU
LOGIN
SUBSCRIBE
Nov
7
Singapore's Hummingbird mulls Hong Kong IPO
just now
Cailian Press
Hummingbird Bioscience, a Singapore-based biotech firm, is said to be considering an IPO in Hong Kong next year, according to people familiar with the matter.
Share
Latest Pulses
See All
Most Recent
News
Coding tools Cursor and Windsurf found using Chinese AI in latest releases
News
Philippine conglomerates offer inroads for China, Vietnam EV brands
News
Bambu Lab’s MakerWorld sues rival platforms for alleged copyright infringement
See All